{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-044010","form_type":"8-K","ticker":"NVNO","cik":"0001661053","company_name":"enVVeno Medical Corp","filed_at":"2023-12-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.977637+00:00","generated_at":"2026-06-07T16:14:53.495552+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"enVVeno stockholders elect Robert C. Gray as Class III director, ratify Marcum LLP as auditor","bullets":["Robert C. Gray elected as Class III director for three-year term (5.48M votes for, 0.89M withheld, 2.78M broker non-votes).","Marcum LLP ratified as independent auditor for FY2023 (9.04M for, 87,979 against, 20,598 abstentions).","Annual meeting held December 5, 2023; 9,148,893 shares represented out of 13,316,636 entitled."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-044010","json":"https://secwatch.observer/filing/0001493152-23-044010.json","markdown":"https://secwatch.observer/filing/0001493152-23-044010.md","text":"https://secwatch.observer/filing/0001493152-23-044010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661053/000149315223044010/0001493152-23-044010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661053/000149315223044010/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T16:14:53.495552+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"79e0f0377756d6185794e5603a55d98bfa93aaed","claim":"enVVeno Medical Corp shareholders approved Ratification of the appointment of independent registered public accounting firm at the 2023-12-05 meeting.","evidence_excerpt":"The appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified. The voting results were as follows: Shares Voted For Shares Voted Against Shares Abstaining Broker Non-Vote 9,040,316 87,979 20,598 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315223044010/0001493152-23-044010-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-05"}],"fact_type":"shareholder_vote"},{"claim_id":"8c908f30320a32a708ec9d7d027902f15c64e2a9","claim":"enVVeno Medical Corp shareholders approved Election of Class III directors at the 2023-12-05 meeting.","evidence_excerpt":"Mr. Robert C. Gray was elected as a Class III director to serve for a three-year term that expires at the 2026 annual meeting of stockholders or until his successor is elected and qualified or until his earlier death, incapacity, removal or resignation. The voting results were as follows: Nominee Shares Voted For Shares Withheld Broker Non-Votes Mr. Robert C. Gray 5,479,538 887,767 2,781,588","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315223044010/0001493152-23-044010-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-05"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}